Based on the data mentioned above, the purpose of DCs-based therapeutics is to increase cDC1 in amplifying tumor identification and destroying tumor cells by the immune system, discoveries presented below in the Chapter Immunotherapy. This evidence concerns the gene MPPE1 and neoplasm.